Atlas Trials

A Study to Check the Safety of Dexlansoprazole and Learn if it Can Treat Symptomatic Nonerosive Gastroesophageal Reflux Disease in Children 2 to 11 Years Old

Clinical trial NCT02616302 · COMPLETED

Trial details

NCT number
NCT02616302
Sponsor
Takeda
Status
COMPLETED
Phase
Phase 2
Study type
INTERVENTIONAL
Gastroesophageal Reflux Disease (GERD)
Start date
2023-02-20
Primary completion
2026-07-21
Enrollment
71

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.